
Calytrix Bio
Developing therapies aimed at a group of rare blood cancers.
About
Developing therapies aimed at a group of rare blood cancers. Calytrix Bio is a privately held biotechnology company backed by JPMorgan Chase that is developing therapies aimed at a group of rare blood cancers.
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Calytrix Bio?
People comparing tools land here. Get listed beside these.
All funding rounds
Key facts
- Website
- calytrixbio.com
- Business model
- B2B
Tech stack
Detected on calytrixbio.com, last scanned 16 Nov 2026. Run your own scan
- Frontend
- jQuery
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Measured, not editorial
Agent Readiness
Above median
Scan yoursSite Speed
Top 25%
PageSpeedData Trust
Below median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Calytrix Bio scores 44. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Calytrix Bio changes
Used Calytrix Bio? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Are there companies like Calytrix Bio?
Yes. We list 6 companies like Calytrix Bio, including Moderna, BioNTech and Pixelgen Technologies.
Is Calytrix Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Calytrix Bio is 60 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
SEC filings, insider activity, nonprofit links and pay benchmarks for Calytrix Bio:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Calytrix Bio and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

